Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for COVID-19 symptoms. The drug, made from a combination of two antibodies, was initially developed as a treatment for those who had already been exposed to…
Read More
AstraZeneca may have included outdated information from COVID-19 trial, NIAID says
AstraZeneca US chief lauds new vaccine, dismisses blood clot concerns AZ US President Ruud Dobber tells ‘Your World’ studies showed no significant clotting side effects AstraZeneca may have provided an incomplete view of the efficacy data related to its COVID-19 vaccine…
Read More
Comparative adjuvant trial evaluates Army-developed ALF in HIV vaccine regimens
A new Phase 1 vaccine study began today that will evaluate experimental prime/boost HIV-1 vaccine regimens formulated with combinations of different adjuvants, including one from the Army Liposome Formulation (ALF) family of adjuvants developed by scientists with the U.S. Military…
Read More
Drug trial that could improve respiratory recovery from COVID-19 now underway
A clinical trial has commenced this week to test whether a drug called Almitrine can help people who are seriously ill with COVID-19 to recover from the disease. Patients suffering from COVID-19 pneumonia often develop very low levels of oxygen,…
Read More
Rabies treatment demonstrated as safe and effective for use in children in first pediatric trial
A treatment, known as KEDRAB (Rabies Immune Globulin [Human]), currently used in the prevention of rabies has been demonstrated to be safe and effective for patients age 17 and under. Results published today in Human Vaccines & Immunotherapeutics report the…
Read More
Vietnam starts human trial of coronavirus vaccine
A Vietnamese pharmaceutical company began testing a coronavirus vaccine on volunteers in Hanoi on Thursday, as developing countries jostle with richer nations to access affordable inoculations. Nanogen’s Nanocovax is one of four under development in Vietnam, and a company representative…
Read More
Immune modulator drugs for COVID-19 focus of major NIH clinical trial
One of the most vexing aspects of the COVID-19 pandemic is the novel coronavirus’s ability to turn the body’s immune system against the body. After the virus has been cleared from the body, the immune system sometimes continues to hurtle…
Read More
Trial shows hydroxychloroquine does not prevent COVID-19 in health care workers
University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus—health care workers. The pre-exposure prophylaxis trial results, which were published in Clinical Infectious Diseases, determined that…
Read More
Investigational ALS drug prolongs patient survival in clinical trial
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial…
Read More
NIH Launches Trial of Antibody Drugs Against COVID-19
WEDNESDAY, Oct. 14, 2020 — A study to assess whether certain approved or experimental drugs are effective against COVID-19 and warrant testing in large clinical trials has been launched by the U.S. National Institutes of Health (NIH). The research will…
Read More